AAPL341.07+5.15 (+1.53%) ▲|ABBV264.34-0.78 (-0.29%) ▼|ABT101.29+0.22 (+0.22%) ▲|ACN176.11-1.30 (-0.73%) ▼|ADBE235.47-3.46 (-1.45%) ▼|AMAT485.00+10.75 (+2.27%) ▲|AMD630.63+1.37 (+0.22%) ▲|AMGN414.61+8.57 (+2.11%) ▲|AMT169.03+1.77 (+1.06%) ▲|AMZN249.67+0.29 (+0.12%) ▲|AVGO352.81+2.45 (+0.70%) ▲|AXP308.89+3.23 (+1.06%) ▲|BA198.07+1.27 (+0.65%) ▲|BAC56.70+0.67 (+1.20%) ▲|BKNG163.95+6.54 (+4.15%) ▲|BLK1,086.31+12.86 (+1.20%) ▲|BMY62.86+1.36 (+2.21%) ▲|BNY150.15-0.04 (-0.03%) ▼|BRK-B505.48+0.30 (+0.06%) ▲|C134.28+2.18 (+1.65%) ▲|CAT821.58+16.33 (+2.03%) ▲|CL86.06+0.74 (+0.87%) ▲|CMCSA21.91-0.22 (-0.99%) ▼|COF200.20+3.59 (+1.83%) ▲|COP127.30-2.04 (-1.58%) ▼|COST922.77+26.29 (+2.93%) ▲|CRM234.02-4.20 (-1.76%) ▼|CSCO106.70-0.27 (-0.25%) ▼|CVS89.13+4.08 (+4.80%) ▲|CVX204.45-1.20 (-0.58%) ▼|DE690.46-4.48 (-0.64%) ▼|DHR224.49+0.72 (+0.32%) ▲|DIS106.15+0.59 (+0.56%) ▲|DUK113.35+0.12 (+0.11%) ▲|EMR158.23+2.09 (+1.34%) ▲|FDX285.85+6.31 (+2.26%) ▲|GD336.72+0.43 (+0.13%) ▲|GE327.09+7.31 (+2.29%) ▲|GEV957.63+2.59 (+0.27%) ▲|GILD150.93+1.24 (+0.83%) ▲|GM82.63+2.06 (+2.56%) ▲|GOOG341.08+2.07 (+0.61%) ▲|GOOGL343.92+1.56 (+0.46%) ▲|GS935.45+12.16 (+1.32%) ▲|HD293.20+1.02 (+0.35%) ▲|HON212.55+0.76 (+0.36%) ▲|IBM225.51-1.55 (-0.68%) ▼|INTC123.00-4.39 (-3.45%) ▼|INTU275.79-1.34 (-0.48%) ▼|ISRG405.18+5.66 (+1.42%) ▲|JNJ271.22+0.54 (+0.20%) ▲|JPM343.06+4.50 (+1.33%) ▲|KO87.81-0.29 (-0.33%) ▼|LIN469.89+1.75 (+0.37%) ▲|LLY1,183.46+1.57 (+0.13%) ▲|LMT519.56-4.14 (-0.79%) ▼|LOW189.28+0.79 (+0.42%) ▲|LRCX315.21+8.05 (+2.62%) ▲|MA567.65+1.57 (+0.28%) ▲|MCD236.50-0.52 (-0.22%) ▼|MDLZ60.25-0.61 (-1.00%) ▼|MDT88.64+0.85 (+0.97%) ▲|META751.66-25.93 (-3.33%) ▼|MMM169.55+2.03 (+1.21%) ▲|MO68.82-0.06 (-0.09%) ▼|MRK148.78+0.80 (+0.54%) ▲|MS196.31-0.01 (-0.01%) ▼|MSFT516.17+18.24 (+3.66%) ▲|MU1,082.28+1.75 (+0.16%) ▲|NEE76.08+0.46 (+0.61%) ▲|NFLX71.15-0.58 (-0.80%) ▼|NKE35.75-0.24 (-0.67%) ▼|NOW135.62-2.16 (-1.57%) ▼|NVDA225.07+0.49 (+0.22%) ▲|ORCL137.10-2.44 (-1.75%) ▼|PEP128.63+0.48 (+0.37%) ▲|PFE28.67+0.26 (+0.92%) ▲|PG146.23+0.55 (+0.38%) ▲|PLTR189.67-2.92 (-1.52%) ▼|PM190.48-1.02 (-0.53%) ▼|QCOM201.97+7.71 (+3.97%) ▲|RTX189.40+0.79 (+0.42%) ▲|SBUX94.86+1.21 (+1.29%) ▲|SCHW99.03-0.46 (-0.46%) ▼|SO82.88-0.01 (-0.01%) ▼|SPG204.82+0.12 (+0.06%) ▲|T25.38-0.07 (-0.28%) ▼|TMO675.00-3.39 (-0.50%) ▼|TMUS165.43+0.08 (+0.05%) ▲|TSLA372.11-5.83 (-1.54%) ▼|TXN278.07+7.42 (+2.74%) ▲|UBER69.62+0.40 (+0.58%) ▲|UNH376.59+1.58 (+0.42%) ▲|UNP273.79-0.28 (-0.10%) ▼|UPS93.96+1.91 (+2.08%) ▲|USB59.33+0.93 (+1.59%) ▲|V367.38-0.60 (-0.16%) ▼|VZ47.08-0.24 (-0.51%) ▼|WFC82.97+0.79 (+0.96%) ▲|WMT107.98+0.39 (+0.36%) ▲|XOM160.59-1.55 (-0.96%) ▼|AAPL341.07+5.15 (+1.53%) ▲|ABBV264.34-0.78 (-0.29%) ▼|ABT101.29+0.22 (+0.22%) ▲|ACN176.11-1.30 (-0.73%) ▼|ADBE235.47-3.46 (-1.45%) ▼|AMAT485.00+10.75 (+2.27%) ▲|AMD630.63+1.37 (+0.22%) ▲|AMGN414.61+8.57 (+2.11%) ▲|AMT169.03+1.77 (+1.06%) ▲|AMZN249.67+0.29 (+0.12%) ▲|AVGO352.81+2.45 (+0.70%) ▲|AXP308.89+3.23 (+1.06%) ▲|BA198.07+1.27 (+0.65%) ▲|BAC56.70+0.67 (+1.20%) ▲|BKNG163.95+6.54 (+4.15%) ▲|BLK1,086.31+12.86 (+1.20%) ▲|BMY62.86+1.36 (+2.21%) ▲|BNY150.15-0.04 (-0.03%) ▼|BRK-B505.48+0.30 (+0.06%) ▲|C134.28+2.18 (+1.65%) ▲|CAT821.58+16.33 (+2.03%) ▲|CL86.06+0.74 (+0.87%) ▲|CMCSA21.91-0.22 (-0.99%) ▼|COF200.20+3.59 (+1.83%) ▲|COP127.30-2.04 (-1.58%) ▼|COST922.77+26.29 (+2.93%) ▲|CRM234.02-4.20 (-1.76%) ▼|CSCO106.70-0.27 (-0.25%) ▼|CVS89.13+4.08 (+4.80%) ▲|CVX204.45-1.20 (-0.58%) ▼|DE690.46-4.48 (-0.64%) ▼|DHR224.49+0.72 (+0.32%) ▲|DIS106.15+0.59 (+0.56%) ▲|DUK113.35+0.12 (+0.11%) ▲|EMR158.23+2.09 (+1.34%) ▲|FDX285.85+6.31 (+2.26%) ▲|GD336.72+0.43 (+0.13%) ▲|GE327.09+7.31 (+2.29%) ▲|GEV957.63+2.59 (+0.27%) ▲|GILD150.93+1.24 (+0.83%) ▲|GM82.63+2.06 (+2.56%) ▲|GOOG341.08+2.07 (+0.61%) ▲|GOOGL343.92+1.56 (+0.46%) ▲|GS935.45+12.16 (+1.32%) ▲|HD293.20+1.02 (+0.35%) ▲|HON212.55+0.76 (+0.36%) ▲|IBM225.51-1.55 (-0.68%) ▼|INTC123.00-4.39 (-3.45%) ▼|INTU275.79-1.34 (-0.48%) ▼|ISRG405.18+5.66 (+1.42%) ▲|JNJ271.22+0.54 (+0.20%) ▲|JPM343.06+4.50 (+1.33%) ▲|KO87.81-0.29 (-0.33%) ▼|LIN469.89+1.75 (+0.37%) ▲|LLY1,183.46+1.57 (+0.13%) ▲|LMT519.56-4.14 (-0.79%) ▼|LOW189.28+0.79 (+0.42%) ▲|LRCX315.21+8.05 (+2.62%) ▲|MA567.65+1.57 (+0.28%) ▲|MCD236.50-0.52 (-0.22%) ▼|MDLZ60.25-0.61 (-1.00%) ▼|MDT88.64+0.85 (+0.97%) ▲|META751.66-25.93 (-3.33%) ▼|MMM169.55+2.03 (+1.21%) ▲|MO68.82-0.06 (-0.09%) ▼|MRK148.78+0.80 (+0.54%) ▲|MS196.31-0.01 (-0.01%) ▼|MSFT516.17+18.24 (+3.66%) ▲|MU1,082.28+1.75 (+0.16%) ▲|NEE76.08+0.46 (+0.61%) ▲|NFLX71.15-0.58 (-0.80%) ▼|NKE35.75-0.24 (-0.67%) ▼|NOW135.62-2.16 (-1.57%) ▼|NVDA225.07+0.49 (+0.22%) ▲|ORCL137.10-2.44 (-1.75%) ▼|PEP128.63+0.48 (+0.37%) ▲|PFE28.67+0.26 (+0.92%) ▲|PG146.23+0.55 (+0.38%) ▲|PLTR189.67-2.92 (-1.52%) ▼|PM190.48-1.02 (-0.53%) ▼|QCOM201.97+7.71 (+3.97%) ▲|RTX189.40+0.79 (+0.42%) ▲|SBUX94.86+1.21 (+1.29%) ▲|SCHW99.03-0.46 (-0.46%) ▼|SO82.88-0.01 (-0.01%) ▼|SPG204.82+0.12 (+0.06%) ▲|T25.38-0.07 (-0.28%) ▼|TMO675.00-3.39 (-0.50%) ▼|TMUS165.43+0.08 (+0.05%) ▲|TSLA372.11-5.83 (-1.54%) ▼|TXN278.07+7.42 (+2.74%) ▲|UBER69.62+0.40 (+0.58%) ▲|UNH376.59+1.58 (+0.42%) ▲|UNP273.79-0.28 (-0.10%) ▼|UPS93.96+1.91 (+2.08%) ▲|USB59.33+0.93 (+1.59%) ▲|V367.38-0.60 (-0.16%) ▼|VZ47.08-0.24 (-0.51%) ▼|WFC82.97+0.79 (+0.96%) ▲|WMT107.98+0.39 (+0.36%) ▲|XOM160.59-1.55 (-0.96%) ▼|
15.6 C
New York
Saturday, September 26, 2026

Tag: information

newssourceFORcompanyinformationcontent1releasesmarket

Orange : Publication du rapport financier du premier semestre 2025 d’Orange

Publication du rapport financier du premier semestre 2025 d’Orange

Meliodays and Celanese Partner for Meliodays’ Development of Hormone-Free Non-Contraceptive IUD designed to Treat Menstrual Pain

MUNICH, July 29, 2025 (GLOBE NEWSWIRE) -- Meliodays Medical and Celanese Corporation (NYSE: CE) have signed an agreement related to Meliodays’ pre-clinical development of MelioOne®, the first hormone-free non-contraceptive intrauterine device (IUD) designed to deliver localized relief for menstrual pain. MelioOne® combines the proven VitalDose® Drug Delivery Platform from Celanese with Meliodays’ innovative IUD design and non-hormonal active pharmaceutical ingredient (API).

Europe’s ECC Approves Decision for Satellite to Low-Power Device Communications; Advances Satellite-based LoRaWAN® IoT

Europe’s ECC approves satellite-to-LP device communications, advances satellite-based IoT. Milestone driven by LoRa Alliance and regulatory collaboration.

Giants Protocol Powers Tokenization of Real Estate for The Assembly Place, Backed by Singapore’s Sovereign Wealth Fund

SINGAPORE, July 29, 2025 (GLOBE NEWSWIRE) -- Giants Protocol, a pioneer in AI-powered real-world asset (RWA) tokenization, has announced a landmark collaboration with Singapore-based co-living operator The Assembly Place (TAP) to tokenize real estate assets. This strategic move showcases the protocol’s ability to transform physical infrastructure into on-chain, yield-generating opportunities. The announcement marks a key milestone in Giants’ journey, having been backed by Singapore’s Sovereign Wealth Fund since inception and now delivering tangible use cases in Asia’s fast-evolving tokenization landscape.

CNOOC Limited Brings On-stream Dongfang 1-1 Gas Field 13-3 Block Development Project

HONG KONG, July 29, 2025 /PRNewswire/ -- CNOOC Limited (the "Company", SEHK: 00883 (HKD Counter) and 80883 (RMB Counter), SSE: 600938) announces today that...

Finalization of Eesti Energia’s takeover bid

On 26 June 2025 the shareholders of Enefit Green AS approved Eesti Energia's takeover of the shares of Enefit Green AS belonging to the minority shareholders of Enefit Green AS and delisting of Enefit Green shares from Nasdaq Tallinn.

WuXi Biologics Singapore CRDMO Hub Advances with the Launch of Modular Drug Product Facility Fabrication

Innovative modular design will accelerate construction and manufacturing timelines, enabling rapid adaptation of manufacturing capacities across diverse product formats.Finished building will be one of...

MetrioPharm’s MP1032 Receives EMA Orphan Drug Designation in Duchenne Muscular Dystrophy

Zurich, July 29, 2025 – MetrioPharm AG, a pharmaceutical company developing drugs for inflammatory and infectious diseases, announced today that the European Medicines Agency has granted Orphan Drug Designation (ODD) to its lead compound, MP1032 for the treatment of children affected by Duchenne muscular dystrophy (DMD). This milestone follows the U.S. FDA's ODD, underscoring MP1032's potential as a first-in-class therapy that could minimize reliance on high-dose corticosteroids, which cause severe side effects like osteoporosis, growth stunting, and metabolic issues.

Share Buyback Transaction Details July 24 – July 28, 2025

PRESS RELEASE                                        

TERMINATION OF CALL OPTION AGREEMENT FOR RENARD PROJECT

MONTREAL, July 29, 2025 /CNW/ - Further to its announcement on 17 June 2025, Winsome Resources (ASX: WR1) (Winsome or the Company) advises that it...

Man Group PLC : Form 8.3 – American Axle & Manufacturing Holdings, Inc.

FORM 8.3

Atari enters into an agreement to invest in Thunderful Group AB

Atari enters into an agreement to invest in Thunderful Group AB

Stellantis Reports First Half 2025 Results Reflecting External Headwinds and Ongoing Recovery Actions; Financial Guidance Re-Established

Stellantis Reports First Half 2025 Results Reflecting External Headwinds and Ongoing Recovery Actions; Financial Guidance Re-Established

Progress on share buyback programme

Progress on share buyback programme

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsInformation

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers